Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Regulatory T Cells in Cancer Biology: A Possible New Target for Biochemical Therapies

Author(s): Dominik Wolf, Holger Rumpold and Anna-Maria Wolf

Volume 6, Issue 5, 2006

Page: [509 - 513] Pages: 5

DOI: 10.2174/138955706776876230

Price: $65

conference banner
Abstract

CD4+CD25+ T cells are essential for maintenance of self-tolerance and therefore have been referred to as regulatory T cells (Treg). Experimental tumor models revealed that Treg are potent inhibitors of an anti-tumor immune response. Treg are expanded in human cancer. Currently, a variety of strategies for the induction of a specific anti-tumor immune response are tested in preclinical and clinical settings. Biochemical strategies modifying and/or depleting Treg in cancer patients for an enhancement of vaccine-based therapeutic concepts will be discussed in detail in this review.

Keywords: Biochemical modification, regulatory T cell, immune evasion, cancer


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy